Laddar...
A robust Bayesian dose-finding design for phase I/II clinical trials
We propose a Bayesian phase I/II dose-finding trial design that simultaneously accounts for toxicity and efficacy. We model the toxicity and efficacy of investigational doses using a flexible Bayesian dynamic model, which borrows information across doses without imposing stringent parametric assumpt...
Sparad:
| I publikationen: | Biostatistics |
|---|---|
| Huvudupphovsmän: | , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Oxford University Press
2016
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5006115/ https://ncbi.nlm.nih.gov/pubmed/26486139 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/biostatistics/kxv040 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|